Dualyx

Dualyx is a biotechnology company developing next-generation immunomodulators, dedicated to creating novel therapies based on Tregs to meet the needs of patients with difficult-to-treat autoimmune diseases. Its goal is to create the next generation of biologics for autoimmune therapy, which, compared to traditional treatments, feature novel mechanisms of action, reduced toxicity, and improved patient outcomes.